Board Meeting20 Jul 2026, 12:18 pm
Sanofi India Board Meeting on Aug 4 to Approve Q1 FY27 Results
AI Summary
Sanofi India Ltd has announced that its Board of Directors will convene on August 4, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results for the quarter and half-year ended June 30, 2026. Additionally, the company confirmed that the trading window, which was closed from July 1, 2026, in anticipation of these results, will reopen on August 7, 2026. This announcement adheres to SEBI's listing regulations.
Key Highlights
- Board meeting scheduled for August 4, 2026.
- To consider and approve Unaudited Financial Results.
- Results are for the quarter and half-year ended June 30, 2026.
- Trading window closure dates confirmed.
- Announcement made as per SEBI listing regulations.
Price Impact
More from SANOFI